治疗药物-话题@MedSci

#治疗药物#

300篇内容 | 2633人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1921718, encodeId=7a7b1921e1852, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=“四大”白血病靶向治疗药物盘点（上）, objectType=article, longId=146387, objectId=fa1814638e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1814638e0c, replyNumber=0, likeNumber=61, createdTime=2018-09-26, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1814638e0c, moduleTitle=“四大”白血病靶向治疗药物盘点（上）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa1814638e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921698, encodeId=c9ae1921698c8, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Ann Neurol：胚胎神经节隆起祖细胞移植有望治疗药物抵抗性癫痫, objectType=article, longId=119745, objectId=6db0119e456a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6db0119e456a, replyNumber=0, likeNumber=82, createdTime=2018-06-25, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6db0119e456a, moduleTitle=Ann Neurol：胚胎神经节隆起祖细胞移植有望治疗药物抵抗性癫痫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6db0119e456a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921695, encodeId=a2d91921695a2, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=2017 AGNP共识指南：神经精神药理学治疗药物检测, objectType=article, longId=114070, objectId=d51e1140e043, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d51e1140e043, replyNumber=0, likeNumber=12, createdTime=2017-10-24, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d51e1140e043, moduleTitle=2017 AGNP共识指南：神经精神药理学治疗药物检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d51e1140e043)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921709, encodeId=eaa71921e09f9, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Alexion收购Wilson Therapeutics公司获得威尔逊病的治疗药物, objectType=article, longId=135056, objectId=850513505659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=850513505659, replyNumber=0, likeNumber=45, createdTime=2018-07-11, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=850513505659, moduleTitle=Alexion收购Wilson Therapeutics公司获得威尔逊病的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=850513505659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921697, encodeId=d943192169ed4, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=2017 共识声明：抗肿瘤坏死因子治疗炎症性肠病治疗药物监测, objectType=article, longId=116861, objectId=998611686141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=998611686141, replyNumber=0, likeNumber=17, createdTime=2017-12-02, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=998611686141, moduleTitle=2017 共识声明：抗肿瘤坏死因子治疗炎症性肠病治疗药物监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=998611686141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921713, encodeId=eeb31921e138a, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=免疫肿瘤治疗药物获批，能否改善肺癌治疗？, objectType=article, longId=141096, objectId=037514109663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=037514109663, replyNumber=0, likeNumber=71, createdTime=2019-04-14, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=037514109663, moduleTitle=免疫肿瘤治疗药物获批，能否改善肺癌治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=037514109663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921691, encodeId=005219216912c, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=读非那雄胺的诞生故事谈前列腺增生的治疗药物及慎用药物, objectType=article, longId=110992, objectId=24e7110992ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24e7110992ed, replyNumber=0, likeNumber=73, createdTime=2017-10-11, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24e7110992ed, moduleTitle=读非那雄胺的诞生故事谈前列腺增生的治疗药物及慎用药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24e7110992ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921702, encodeId=8a3e1921e0251, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=2018年值得关注的肿瘤免疫治疗药物, objectType=article, longId=125579, objectId=968d1255e9cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968d1255e9cf, replyNumber=0, likeNumber=95, createdTime=2018-02-17, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968d1255e9cf, moduleTitle=2018年值得关注的肿瘤免疫治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=968d1255e9cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921690, encodeId=7f9c192169001, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=ANN ONCOL:肿瘤类型和免疫治疗药物类别的不同对免疫治疗不良事件的发生差异如何？, objectType=article, longId=108712, objectId=caf6108e122c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caf6108e122c, replyNumber=0, likeNumber=60, createdTime=2018-05-25, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caf6108e122c, moduleTitle=ANN ONCOL:肿瘤类型和免疫治疗药物类别的不同对免疫治疗不良事件的发生差异如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=caf6108e122c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921686, encodeId=5af41921686d6, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=FDA批准AML新靶向治疗药物, objectType=article, longId=107512, objectId=441a10e512b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=441a10e512b8, replyNumber=0, likeNumber=85, createdTime=2018-03-19, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=441a10e512b8, moduleTitle=FDA批准AML新靶向治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=441a10e512b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921704, encodeId=1a101921e0422, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物, objectType=article, longId=130632, objectId=0a5c130632d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a5c130632d4, replyNumber=0, likeNumber=58, createdTime=2018-09-20, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a5c130632d4, moduleTitle=卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a5c130632d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921707, encodeId=ce211921e0762, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=色视症的基因治疗药物获EMA的优先资格, objectType=article, longId=131472, objectId=5cef1314e28d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cef1314e28d, replyNumber=0, likeNumber=81, createdTime=2019-01-13, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cef1314e28d, moduleTitle=色视症的基因治疗药物获EMA的优先资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cef1314e28d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921682, encodeId=c77719216821b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=J Oncol Pra：关注癌症治疗药物之间相互作用导致的不良临床后果！, objectType=article, longId=103276, objectId=1ce71032e6c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ce71032e6c1, replyNumber=0, likeNumber=68, createdTime=2017-09-11, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ce71032e6c1, moduleTitle=J Oncol Pra：关注癌症治疗药物之间相互作用导致的不良临床后果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ce71032e6c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921687, encodeId=635d192168ee4, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=欧盟批准神经营养性角膜炎治疗药物, objectType=article, longId=107711, objectId=8beb10e711be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8beb10e711be, replyNumber=0, likeNumber=91, createdTime=2018-04-13, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8beb10e711be, moduleTitle=欧盟批准神经营养性角膜炎治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8beb10e711be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921689, encodeId=41d419216897c, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAHA：肿瘤治疗药物贝伐单抗会增加心血管不良事件风险！, objectType=article, longId=108622, objectId=e85210862207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e85210862207, replyNumber=0, likeNumber=67, createdTime=2017-11-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e85210862207, moduleTitle=JAHA：肿瘤治疗药物贝伐单抗会增加心血管不良事件风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e85210862207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921706, encodeId=3cb01921e060a, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Lancet Respir Med：学龄前儿童病毒相关喘息有了靠谱的治疗药物, objectType=article, longId=131188, objectId=58231311882e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58231311882e, replyNumber=0, likeNumber=58, createdTime=2018-04-29, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58231311882e, moduleTitle=Lancet Respir Med：学龄前儿童病毒相关喘息有了靠谱的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58231311882e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921703, encodeId=b1a61921e0318, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究, objectType=article, longId=126027, objectId=39af12602e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39af12602e4e, replyNumber=0, likeNumber=58, createdTime=2018-02-28, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39af12602e4e, moduleTitle=JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39af12602e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921681, encodeId=50f9192168194, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Nat Microbiol：乙型肝炎治疗药物开发新近进展, objectType=article, longId=103000, objectId=a7981030009b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7981030009b, replyNumber=0, likeNumber=95, createdTime=2017-12-04, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7981030009b, moduleTitle=Nat Microbiol：乙型肝炎治疗药物开发新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7981030009b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921694, encodeId=61dd1921694b9, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=晚期乳腺癌内分泌治疗药物纳入国家医保, objectType=article, longId=112076, objectId=58b01120e644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58b01120e644, replyNumber=0, likeNumber=74, createdTime=2018-06-12, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58b01120e644, moduleTitle=晚期乳腺癌内分泌治疗药物纳入国家医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58b01120e644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921700, encodeId=25df1921e0051, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=西安杨森新型血液肿瘤治疗药物亿珂(R)在中国快速上市, objectType=article, longId=120168, objectId=d63b120168b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d63b120168b5, replyNumber=0, likeNumber=68, createdTime=2018-06-25, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d63b120168b5, moduleTitle=西安杨森新型血液肿瘤治疗药物亿珂(R)在中国快速上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d63b120168b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗药物

2020-05-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

“四大”白血病靶向治疗药物盘点（上）

2018-09-26

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Ann Neurol：胚胎神经节隆起祖细胞移植有望治疗药物抵抗性癫痫

2018-06-25

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

2017 AGNP共识指南：神经精神药理学治疗药物检测

2017-10-24

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Alexion收购Wilson Therapeutics公司获得威尔逊病的治疗药物

2018-07-11

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

2017 共识声明：抗肿瘤坏死因子治疗炎症性肠病治疗药物监测

2017-12-02

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

免疫肿瘤治疗药物获批，能否改善肺癌治疗？

2019-04-14

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

读非那雄胺的诞生故事谈前列腺增生的治疗药物及慎用药物

2017-10-11

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

2018年值得关注的肿瘤免疫治疗药物

2018-02-17

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

ANN ONCOL:肿瘤类型和免疫治疗药物类别的不同对免疫治疗不良事件的发生差异如何？

2018-05-25

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

FDA批准AML新靶向治疗药物

2018-03-19

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物

2018-09-20

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

色视症的基因治疗药物获EMA的优先资格

2019-01-13

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

J Oncol Pra：关注癌症治疗药物之间相互作用导致的不良临床后果！

2017-09-11

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

欧盟批准神经营养性角膜炎治疗药物

2018-04-13

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAHA：肿瘤治疗药物贝伐单抗会增加心血管不良事件风险！

2017-11-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Lancet Respir Med：学龄前儿童病毒相关喘息有了靠谱的治疗药物

2018-04-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAMA Neurol：利妥昔单抗、富马酸二甲酯、芬戈莫德、那他珠单抗以及其他症状缓解治疗药物对复发缓解多发性硬化症的治疗效果比较研究

2018-02-28

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Nat Microbiol：乙型肝炎治疗药物开发新近进展

2017-12-04

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

晚期乳腺癌内分泌治疗药物纳入国家医保

2018-06-12

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

西安杨森新型血液肿瘤治疗药物亿珂(R)在中国快速上市

2018-06-25

科室
- - 订阅+
  - 更多科室
工具
服务